You are currently viewing a new version of our website. To view the old version click .

Addressing Alzheimer’s Disease: Blueprints and Therapeutic Hints

This special issue belongs to the section “Clinical Neurology“.

Special Issue Information

Dear Colleagues,

Alzheimer’s disease (AD), the most abundant form of dementia, currently represents a harsh social and economic issue worldwide. Rarely triggered by genetic mutations, AD is most commonly associated with a variety of risk factors, including aging, ApoE protein, cardiovascular diseases, diabetes and factors generally connected with increased inflammation levels (e.g., Western diet and sedentary lifestyle). Only a few symptomatic treatments are currently available; although several disease modifying agents are being tested in preclinical and clinical trials. Due to the heterogeneity of AD pathological hallmarks and clinical manifestations, research efforts are now being directed toward multitarget approaches and ad personam therapies. Only a precise and comprehensive understanding of the mechanisms triggering, developing and aggravating AD will guarantee an adequate response to the compelling need for effective treatments. This Special Issue of the Journal of Clinical Medicine will report on the current trends in AD prevention and curative strategies, highlighting new targets of intervention as well as novel therapeutic approaches.

Assist. Prof. Patrizia Giannoni
Dr. Sylvie Claeysen
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Alzheimer’s
  • therapeutic target
  • multitarget-directed ligands
  • inflammation
  • vasculature
  • microbiota
  • prevention
  • biomarkers
  • diet

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
J. Clin. Med. - ISSN 2077-0383